Here are the key results: STEP 1 Trial (Standard 2.4 mg Dose) Participants lost an average of approximately 14.9% of their body weight over 68 weeks One-third of participants lost 20% or more of their body weight For a patient starting at 100 kg, this equates to approximately 15 kg (about 2 stone 5 lbs) of weight loss STEP 8 Trial (Higher 7.2 mg Dose) The newer, higher dose achieved approximately 20.7% body weight loss Nearly half of participants lost 20% or more of their body weight This dose narrows the gap between Wegovy and Mounjaro in terms of average weight loss What This Means in Practical Terms For patients in Northern Ireland starting Wegovy at a typical body weight, the results translate to meaningful, life-changing weight loss: Starting weight 90 kg (14 stone 2 lbs): Expected loss of approximately 13.4 kg (2 stone 2 lbs) Starting weight 105 kg (16 stone 7 lbs): Expected loss of approximately 15.6 kg (2 stone 6 lbs) Starting weight 120 kg (18 stone 13 lbs): Expected loss of approximately 17.9 kg (2 stone 12 lbs) Beyond the weight loss itself, clinical trial participants consistently reported improvements in blood pressure, blood sugar control, cholesterol levels, waist circumference, and quality of life
And are different outcomes found depending on the prescriber and the type of follow-up, he added
There are even conflicting records of how many boxes were delivered: One document lists 10,000 units and another 20,000
The genetic test maps 14 metabolic pathways and 150+ peptide-related insights specific to each patient's physiology
[Abstract] CNS Neurosci Ther
Not All Versions Are Created Equal Generic and compounded versions may expand, but not all are high-quality or clinically backed
